Basic Research is systematic inquiry conducted to advance fundamental knowledge and theoretical understanding of natural phenomena, physical laws, or mathematical principles without immediate practical application as its primary objective. Unlike applied research, which targets specific problems or commercial outcomes, basic research seeks to answer foundational questions about how the universe works, driven by curiosity and
Bayesian Networks refers to probabilistic graphical models that represent relationships between variables using directed graphs, where nodes represent variables and edges show probabilistic dependencies. These networks use Bayes’ theorem to calculate conditional probabilities, enabling systems to reason under uncertainty and make predictions based on incomplete information, making them valuable for diagnostic systems, risk assessment, and
Bayh-Dole Act is a United States federal law enacted in 1980 that allows universities, nonprofit research institutions, and small businesses to retain ownership of inventions developed with federal funding and to license those inventions exclusively to commercial partners. Formally titled the Patent and Trademark Law Amendments Act, the legislation fundamentally reshaped the relationship between academic
Biologics License Application (BLA) is the formal regulatory submission required by the U.S. Food and Drug Administration to obtain approval to market a biologic product in the United States. Unlike new drug applications for small-molecule pharmaceuticals, a BLA must demonstrate not only safety and efficacy through clinical trials but also the manufacturing consistency and product
Black Box refers to any system, device, or algorithm where the internal workings are hidden, inaccessible, or incomprehensible, even though the inputs and outputs can be observed and measured. Originally coined in cybernetics and systems theory, the term describes situations where you can see what goes in and what comes out, but the transformation process
Breakthrough Therapy Designation (BTD) is an FDA regulatory pathway established in 2012 that expedites development and review of drugs and biologics intended to treat serious or life-threatening conditions when preliminary clinical evidence demonstrates substantial improvement over existing therapies. Unlike Fast Track or Accelerated Approval, BTD provides intensive FDA guidance on development planning, organizational commitment including
Bridge Funding is a form of short-term capital provided to organizations, typically startups or research institutions, to maintain operations during the transition between major funding rounds or grant cycles. The financing covers a critical gap period when existing funds have been exhausted but new funding has not yet closed, preventing layoffs, project delays, or loss
